Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 01, 2008 (Vol. 28, No. 5)

JoVE: Journal of Visualized Experiments

URL:www.jove.com/
  • Well done videos
  • None
By Jove, I’ll wager you can’t figure out from the title of this one what it contains. OK, time’s up. Designed as a “video journal for biological research,” JoVE greets visitors to the opening page with live motion videos. At first glance, that seems a bit gimmicky, but the more I thought about it, the more sense it made to have a video-rich site for biologists. As noted at JoVE, reproducing advanced state-of-the-art techniques in newly published studies is often problematic, so why not take an expert at the technique, videotape them, and the stream the result on the Web? Indeed, the real question should be why someone hasn’t done this before. Highlights of available videos at press time included Fabrication of Thermoplastic Microfluidic Channels, Isolation of Mouse Lymph Notes Using Miltenyi MACS Purification, and Pyrosequencing – A Simple Method for Accurate Genotyping. There are a few treasures here to discover. An excellent idea well done.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »